To further explore the relationship between LINC00511 expression and clinicopathological indexes in patients with GBM, we divided the 36 patients with GBM into two groups of those with relatively high or low LINC00511 expression according to the median level of LINC00511 (n = 18 ≥ median; n = 18 ≤ median) (Figure 1D and Table S1). This evidence concerns the gene LINC00511 and glioblastoma.